CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- 4 Open-market buy Member of 10% owner group bought 6,700 shares at an average $4.14 ($27,738)
- 4 Open-market buy Member of 10% owner group bought 11,000 shares at an average $4.17 ($45,847)
- 4 Open-market buy Chief Executive Officer bought 800 shares at $3.84 ($3,072)
- 4 Open-market buy Chief Executive Officer bought 18,000 shares at an average $0.28 ($5,126)
- 4 Grant or award Director acquired 130,000 shares (grant or award)
- 4 Grant or award Director acquired 130,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Member of 10% owner group bought 130,000 shares at $0.29 ($37,700)
- 4 Open-market buy Member of 10% owner group bought 150,000 shares at $0.35 ($52,500)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Member of 10% owner group bought 939,600 shares at $0.30 ($281,880)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 130,000 shares (grant or award)
Page 10 of 17 · 329 filings